{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:22:15Z","timestamp":1787775735883,"version":"build-2784847793"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>\n                      To report a case of\n                      <jats:italic toggle=\"yes\">Toxoplasma<\/jats:italic>\n                      retinochoroiditis that was complicated by macular infarction following intravitreal clindamycin injection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A 32-year-old otherwise healthy woman with the diagnosis of reactivation of\n                      <jats:italic toggle=\"yes\">Toxoplasma<\/jats:italic>\n                      retinochoroiditis in her right eye, underwent intravitreal clindamycin injection. Shortly after injection, the visual acuity deteriorated, and the fundus examination revealed an extensive area of macular necrosis accompanied by vascular occlusion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The patient was observed. Unfortunately, the condition did not improve over time and resulted in a large area of retinal atrophy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Macular infarction should be considered a rare but disastrous complication that can result in severe, irreversible visual loss.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/joco.joco_150_20","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T11:59:13Z","timestamp":1634903953000},"page":"349-353","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Macular Infarction Following Intravitreal Clindamycin Injection"],"prefix":"10.4103","volume":"33","author":[{"given":"Alireza","family":"Hedayatfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Zand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooshang","family":"Faghihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzhang","family":"Gordiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20240910","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ophtha.2012.07.061","article-title":"Interventions for toxoplasma retinochoroiditis: A report by the American Academy of Ophthalmology","volume":"120","author":"Kim","year":"2013","journal-title":"Ophthalmology"},{"key":"R2-21-20240910","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1051\/parasite\/2010173177","article-title":"Factors of occurrence of ocular toxoplasmosis","volume":"17","author":"Talabani","year":"2010","journal-title":"A review. Parasite"},{"key":"R3-21-20240910","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ophtha.2010.04.020","article-title":"Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis","volume":"118","author":"Soheilian","year":"2011","journal-title":"Ophthalmology"},{"key":"R4-21-20240910","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3928\/1542-8877-20010501-03","article-title":"Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis","volume":"32","author":"Kishore","year":"2001","journal-title":"Ophthalmic Surg Lasers"},{"key":"R5-21-20240910","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1167\/iovs.05-0604","article-title":"Acute aminoglycoside retinal toxicity in vivo and in vitro","volume":"46","author":"Hancock","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-21-20240910","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/IAE.0b013e31804b3f0d","article-title":"Intravitreal clindamycin for toxoplasmic retinochoroiditis","volume":"27","author":"Sobrin","year":"2007","journal-title":"Retina"},{"key":"R7-21-20240910","doi-asserted-by":"crossref","first-page":"811","DOI":"10.5301\/EJO.2011.6403","article-title":"Prevalence, clinical characteristics, and causes of vision loss in patients with ocular toxoplasmosis","volume":"21","author":"London","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"R8-21-20240910","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1590\/S0004-27492005000600023","article-title":"Macular infarction after intravitreal injection of amikacin: Case report","volume":"68","author":"Almeida","year":"2005","journal-title":"Arq Bras Oftalmol"},{"key":"R9-21-20240910","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/bjo.86.3.359","article-title":"Macular infarction after intravitreal amikacin: Mounting evidence against amikacin","volume":"86","author":"Galloway","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"R10-21-20240910","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/archopht.1986.01050150067028","article-title":"Macular infarction after endophthalmitis treated with vitrectomy and intravitreal gentamicin","volume":"104","author":"Conway","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"R11-21-20240910","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.5301\/ejo.5000874","article-title":"Hemorrhagic occlusive retinal vasculitis after inadvertent intraocular perforation with gentamycin injection","volume":"27","author":"Querques","year":"2017","journal-title":"Eur J Ophthalmol"},{"key":"R12-21-20240910","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/ICU.0b013e328338679a","article-title":"Complications of intravitreal injections","volume":"21","author":"Sampat","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"R13-21-20240910","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4103\/0301-4738.18910","article-title":"Optical coherence tomography in Amikacin-induced macular infarction","volume":"53","author":"Venkatesh","year":"2005","journal-title":"Indian J Ophthalmol"},{"key":"R14-21-20240910","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ophtha.2015.03.016","article-title":"Postoperative hemorrhagic occlusive retinal vasculitis: Expanding the clinical spectrum and possible association with vancomycin","volume":"122","author":"Witkin","year":"2015","journal-title":"Ophthalmology"},{"key":"R15-21-20240910","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000365442","article-title":"Hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy","volume":"5","author":"Kelkar","year":"2014","journal-title":"Case Rep Ophthalmol"},{"key":"R16-21-20240910","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.3341\/jkos.2015.56.11.1804","article-title":"Macular Infarction Following Intravitreal Triamcinolone Injection for Treatment of Central Retinal Vein Occlusion","volume":"56","author":"Lee","year":"2015","journal-title":"J Korean Ophthalmol Soc"},{"key":"R17-21-20240910","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s10792-017-0698-9","article-title":"Bilateral macular infarction after gemcitabine and carboplatin chemotherapy","volume":"38","author":"Behera","year":"2018","journal-title":"Int Ophthalmol"},{"key":"R18-21-20240910","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10633-017-9599-5","article-title":"Safety of intravitreal clindamycin in albino rabbit eyes","volume":"135","author":"Habot-Wilner","year":"2017","journal-title":"Doc Ophthalmol"},{"key":"R19-21-20240910","first-page":"615","article-title":"Toxicity of selected antibiotics in vitreous replacement fluid","volume":"9","author":"Stainer","year":"1977","journal-title":"Ann Ophthalmol"},{"key":"R20-21-20240910","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10792-012-9634-1","article-title":"Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: A prospective randomized clinical trial","volume":"33","author":"Baharivand","year":"2013","journal-title":"Int Ophthalmol"},{"key":"R21-21-20240910","first-page":"4160837","article-title":"Intravitreal clindamycin and dexamethasone combined with systemic oral antitoxoplasma therapy versus intravitreal therapy alone in the management of toxoplasma retinochoroiditis: A retrospective study","volume":"2018","author":"Bor'i","year":"2018","journal-title":"J Ophthalmol"},{"key":"R22-21-20240910","doi-asserted-by":"crossref","first-page":"e15428","DOI":"10.5812\/ircmj.15428","article-title":"Intravitreal clindamycin in the treatment of unresponsive zone one toxoplasmic chorioretinitis: A case report","volume":"16","author":"Hosseini","year":"2014","journal-title":"Iran Red Crescent Med J"},{"key":"R23-21-20240910","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.exer.2008.03.011","article-title":"In vitro benzyl alcohol cytotoxicity: Implications for intravitreal use of triamcinolone acetonide","volume":"86","author":"Chang","year":"2008","journal-title":"Exp Eye Res"},{"key":"R24-21-20240910","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1755-3768.2008.01406.x","article-title":"Retinal artery occlusion following intravitreal anti-VEGF therapy","volume":"88","author":"Hanno","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R25-21-20240910","first-page":"153","article-title":"Involutional macular thinning","volume":"93","author":"Morgan","year":"1986","journal-title":"A pre-macular hole condition. Ophthalmology"},{"key":"R26-21-20240910","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/ijo.IJO_67_20","article-title":"Ischemic macular hole in central retinal artery occlusion","volume":"68","author":"Sen","year":"2020","journal-title":"Indian J Ophthalmol"}],"container-title":["Journal of Current Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/joco.joco_150_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:40:54Z","timestamp":1787773254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/joco.joco_150_20"}},"subtitle":["A Case Report"],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/joco.joco_150_20","relation":{},"ISSN":["2452-2325"],"issn-type":[{"value":"2452-2325","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}